Haemonetics Corp. engages in the development and distribution of hematology products and solutions. The company is headquartered in Boston, Massachusetts and currently employs 3,023 full-time employees. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). The company also offers solutions for structural heart and endovascular procedures.
Mr. Christopher Simon est le President de Haemonetics Corp, il a rejoint l'entreprise depuis 2016.
Quelle est la performance du prix de l'action HAE ?
Le prix actuel de HAE est de $58.58, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Haemonetics Corp ?
Haemonetics Corp appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Haemonetics Corp ?
La capitalisation boursière actuelle de Haemonetics Corp est de $2.7B
Est-ce que Haemonetics Corp est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 11 analystes ont établi des notations d'analystes pour Haemonetics Corp, y compris 4 achat fort, 6 achat, 5 maintien, 0 vente et 4 vente forte